Sana Biotechnology, Inc. Share Price Today, Financials & AI Analysis — Stockinder

Jarvis is thinking

Sana Biotechnology, Inc. Share Price Today, Financials & AI Analysis — Stockinder

Income Statement

	2025-12-31	2024-12-31	2021-12-31
Profit from core operations after subtracting the cost of revenue and operating expenses like R&D and marketing, but before interest and taxes.	-$250.32M	-$272.72M	-$356.91M
The company's bottom-line profit after all expenses, interest, and taxes are subtracted.	-$244.17M	-$266.76M	-$355.93M
Net income divided by the number of shares outstanding — profit attributable to each share.	$0.00	$-1.00	$-2.14
Like basic EPS, but accounts for shares that could be created from stock options or convertible securities — a more conservative per-share profit figure.	$0.00	$-1.00	–

Balance Sheet

	2025-12-31	2024-12-31	2021-12-31
Cash and highly liquid short-term investments the company can access almost immediately.	$71.87M	$127.57M	$253.03M
Everything the company owns that has value — cash, property, inventory, investments, and more.	$416.89M	$501.02M	$1.13B
Everything the company owes — debt, unpaid bills, and other obligations.	$256.01M	$250.52M	$400.90M
What would be left for shareholders if the company sold all its assets and paid off all its debts — total assets minus total liabilities.	$160.88M	$250.50M	$728.50M

Cash Flow Statement

	2025-12-31	2024-12-31	2021-12-31
Actual cash generated by the core business, as opposed to accounting profit, which can include non-cash items.	-$143.83M	-$223.15M	-$251.05M
Cash spent on physical assets like property, equipment, and infrastructure to maintain or grow the business.	$938000	$33.43M	$29.86M
Cash left over after capital expenditures — money the company could use for dividends, buybacks, debt repayment, or reinvestment.	-$144.77M	-$256.58M	-$280.92M